Cai Xu - Concepedia

Author

Cai Xu

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

C Xu, C. Xu, Cai Xu, Cai, Xu, Cheng-Hua Xu, Chengmin Xu, Nie, Hongwei, X CAI, X Cai, X. Cai

145

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Fudan University Shanghai Cancer Center Shanghai Medical College of Fudan University Fudan University Heidelberg University

About

Cai Xu is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	792
2	Health Sciences	4	4	256
3	Engineering	2	2	69
4	Biomedical Engineering	1	1	22
5	Biostatistics	1	1	22

Cai Xu

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Lymphocyte Nadir and Esophageal Cancer Survival Outcomes After Chemoradiation Therapy Rajayogesh Davuluri, Wen Jiang, Penny Fang, International Journal of Radiation OncologyBiologyPhysics EsophagusEsophageal CancerMedicinePathologyOncology	2017	247
Comparative Outcomes After Definitive Chemoradiotherapy Using Proton Beam Therapy Versus Intensity Modulated Radiation Therapy for Esophageal Cancer: A Retrospective, Single-Institutional Analysis Mian Xi, Cai Xu, Zhongxing Liao, International Journal of Radiation OncologyBiologyPhysics Surgical OncologyEsophageal CancerRadiation TherapyMedicineOutcomes Research	2017	100
Long non-coding RNA RHPN1-AS1 promotes tumorigenesis and metastasis of ovarian cancer by acting as a ceRNA against miR-596 and upregulating LETM1 Junrong Wang, Weimin Ding, Yingke Xu, Aging	2020	96
Dosimetric comparison to the heart and cardiac substructure in a large cohort of esophageal cancer patients treated with proton beam therapy or Intensity-modulated radiation therapy Yutaka Shiraishi, Cai Xu, Jinzhong Yang, Radiotherapy and Oncology Proton Beam TherapyRadiation MedicineEsophageal Cancer PatientsEsophageal CancerRadiation Therapy	2017	86
High lymphocyte count during neoadjuvant chemoradiotherapy is associated with improved pathologic complete response in esophageal cancer Penny Fang, Wen Jiang, Rajayogesh Davuluri, Radiotherapy and Oncology High Lymphocyte CountNeoadjuvant ChemoradiotherapyEsophageal CancerMedicineImmunology	2018	72
The impact of histology on recurrence patterns in esophageal cancer treated with definitive chemoradiotherapy Mian Xi, Cai Xu, Zhongxing Liao, Radiotherapy and Oncology EsophagusEsophageal CancerMedicineCancer RecurrenceRecurrence Patterns	2017	70
Definitive Chemoradiation Therapy for Esophageal Cancer in the Elderly: Clinical Outcomes for Patients Exceeding 80 Years Old Cai Xu, Mian Xi, Amy C. Moreno, International Journal of Radiation OncologyBiologyPhysics Geriatric OncologyEsophagusEsophageal CancerGeriatricsMedicine	2017	48
The emerging field of radiomics in esophageal cancer: current evidence and future potential Peter S.N. van Rossum, Cai Xu, David Fried, Translational Cancer Research EngineeringEsophageal CancerImage FeaturesPathologyQuantitative Image Analysis	2016	47
Heart and lung doses are independent predictors of overall survival in esophageal cancer after chemoradiotherapy Cai Xu, Lanwei Guo, Zhongxing Liao, Clinical and Translational Radiation Oncology	2019	47
Contrast of Digital and Health Literacy Between IT and Health Care Specialists Highlights the Importance of Multidisciplinary Teams for Digital Health—A Pilot Study André Pfob, Chris Sidey‐Gibbons, Maximilian Schuessler, JCO Clinical Cancer Informatics	2021	41

Page 1